Items where authors include "Fernandez, C."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ow, P.-L., Alderson, S.L. et al. (11 more authors) (2025) Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial. Gut. ISSN 0017-5749

Gale, C.P., Stocken, D.D., Aktaa, S. et al. (11 more authors) (2024) Effectiveness of the GRACE risk score according to troponin elevation in patients admitted with non-ST elevation acute coronary syndrome: a post-hoc analysis of the UKGRIS cluster RCT. European Heart Journal, 45 (Supplement_1). ehae666.1690. ISSN 0195-668X

Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ford, A.C. orcid.org/0000-0001-6371-4359, Alderson, S.L. orcid.org/0000-0002-5418-0495 et al. (19 more authors) (2024) Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT. Health Technology Assessment, 28 (66). ISSN 1366-5278

Teasdale, E., Everitt, H., Alderson, S. et al. (19 more authors) (2024) Low-dose amitriptyline for irritable bowel syndrome (IBS): a qualitative study of patients' and GPs' views and experiences. British Journal of General Practice. BJGP.2024.0303. ISSN 0960-1643

Useche, S.A. orcid.org/0000-0002-5099-4627, Alonso, F. orcid.org/0000-0002-9482-8874, Boyko, A. et al. (32 more authors) (2024) Using demographic, psychosocial, behavioural and safety-related factors to assess cyclists' behaviour: A comparative approach across 19 countries. Data in Brief, 54. 110278. ISSN 2352-3409

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Pontarini, E. orcid.org/0000-0003-0439-0344, Sciacca, E. orcid.org/0000-0001-7525-1558, Chowdhury, F. et al. (28 more authors) (2024) Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS). Arthritis & Rheumatology, 76 (5). pp. 763-776. ISSN 2326-5191

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Ford, A.C., Wright-Hughes, A., Alderson, S.L. et al. (65 more authors) (2023) Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. ISSN 0140-6736

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Everett, C.C., Berry, C., McCann, G.P. orcid.org/0000-0002-5542-8448 et al. (14 more authors) (2023) Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2. Open Heart, 10 (1). ARTN e002221. ISSN 2053-3624

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Heller, S.R. orcid.org/0000-0002-2425-9565, Everett, C.C. et al. (11 more authors) (2023) Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial. Diabetes Care, 46 (2). pp. 441-449. ISSN 0149-5992

Ajjan, R.A. orcid.org/0000-0002-1636-3725, Heller, S.R. orcid.org/0000-0002-2425-9565, Everett, C.C. et al. (11 more authors) (2023) Multicenter randomized trial of intermittently scanned continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes and recent-onset acute myocardial infarction: results of the LIBERATES trial. Diabetes Care, 46 (2). dc221219. ISSN 0149-5992

Meng, B., Abdullahi, A., Ferreira, I.A.T.M. et al. (219 more authors) (2022) Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature, 603 (7902). pp. 706-714. ISSN 0028-0836

Smith, I.L. orcid.org/0000-0002-8326-1075, Gilberts, R. orcid.org/0000-0003-3326-7900, Brown, S. orcid.org/0000-0002-1840-3786 et al. (14 more authors) (2022) Comparison of ALitretinoin with PUVA as the first-line treatment in patients with severe chronic HAnd eczema (ALPHA): study protocol for a randomised controlled trial. BMJ Open, 12 (2). e060029. ISSN 2044-6055

Everett, C.C., Reynolds, C., Fernandez, C. et al. (6 more authors) (2020) Rationale and design of the LIBERATES trial : protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction. Diabetes and Vascular Disease Research, 17 (5). ISSN 1479-1641